Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10 CAD | -1.48% |
|
-0.30% | +8.46% |
17/05 | Tranche Update on BioSyent Inc. (TSXV:RX)'s Equity Buyback Plan announced on December 13, 2023. | CI |
17/05 | BioSyent Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.46% | 8.47Cr | |
+55.35% | 82TCr | |
+32.07% | 60TCr | |
-0.10% | 38TCr | |
+15.47% | 32TCr | |
+13.10% | 31TCr | |
+16.11% | 25TCr | |
+13.97% | 23TCr | |
+16.54% | 18TCr | |
+4.31% | 17TCr |
- Stock Market
- Equities
- RX Stock
- News BioSyent Inc.
- Transcript : BioSyent Inc., Q3 2020 Earnings Call, Nov 26, 2020